Interferon and Octreotide to Treat Zollinger-Ellison Syndrome and Advanced Non-B Islet Cell Cancer - Contacts and Locations

Home

Interferon and Octreotide to Treat Zollinger-Ellison Syndrome and Advanced Non-B Islet Cell Cancer

This study has been completed.

Study NCT00001228. Last updated on September 7, 2007. Information provided by National Institutes of Health Clinical Center (CC)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00001228

Locations


United States, Maryland
	National Institutes of Health Clinical Center, 9000 Rockville Pike
	Bethesda, Maryland, United States, 20892

Sponsors and Collaborators

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)